Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.34 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | GHSR | Q92847 | 1/20 | 0.34 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31569147 | 0.82 | POLB (0.44) | GPR119MAPTPOLB | |
| SCHEMBL31569084 | 0.82 | POLB (0.44) | GPR119MAPTPOLB | |
| SCHEMBL31505424 | 0.80 | MAP4K4 (0.38) | GPR119NR1H2MAPTNPC1UCHL1 | |
| SCHEMBL31568944 | 0.80 | ESR2 (0.36) | NR1H2MAPTNPC1GHSRALDH1A1 | |
| SCHEMBL31505360 | 0.80 | MAP4K4 (0.38) | GPR119NR1H2MAPTNPC1UCHL1 | |
| SCHEMBL4793137 | 0.80 | NR1H2 (0.40) | GPR119NR1H2POLBNPC1UCHL1 | |
| SCHEMBL19089271 | 0.79 | MAP4K4 (0.39) | NR1H2MAPTUCHL1MAP4K4GHSR | |
| SCHEMBL20548830 | 0.79 | MAP4K4 (0.39) | NR1H2MAPTUCHL1MAP4K4GHSR | |
| SCHEMBL19089267 | 0.79 | MAP4K4 (0.39) | NR1H2MAPTUCHL1MAP4K4GHSR | |
| SCHEMBL19089265 | 0.79 | MAP4K4 (0.39) | NR1H2MAPTUCHL1MAP4K4GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025101780-A1 | PHARMACOLOGICAL CORRECTORS OF RHODOPSIN AND USES THEREOF | OCTANT, INC. (US) | 2025-05-15 | — | — | WO | disclosed |